Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126530381 | 12653038 | 1 | I | 20160808 | 20160815 | 20160815 | EXP | PHHY2016US107756 | SANDOZ | HAROON N, RAZA SM, BHAT ZY. HYPOMAGNESEMIA AND CHEMOTHERAPY, DIAGNOSTIC DILEMMA, AND TREATMENT CHALLENGE: CASE REPORT AND LITERATURE REVIEW. AMERICAN JOURNAL OF THERAPEUTICS. 2016;23:E1085-90 | 63.00 | YR | F | Y | 0.00000 | 20160815 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126530381 | 12653038 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 75985 | ||||||||||
| 126530381 | 12653038 | 2 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 3 | C | BENADRYL /00647601/ | CAMPHORDIPHENHYDRAMINEINC OXIDE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 4 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 5 | C | HYDROCODONE | HYDROCODONE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 7 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 9 | C | CELECOXIB. | CELECOXIB | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 10 | C | LORAZEPAM. | LORAZEPAM | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 11 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 12 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 13 | C | LOPERAMIDE | LOPERAMIDE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 14 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 126530381 | 12653038 | 15 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126530381 | 12653038 | 1 | Product used for unknown indication |
| 126530381 | 12653038 | 2 | Product used for unknown indication |
| 126530381 | 12653038 | 3 | Product used for unknown indication |
| 126530381 | 12653038 | 4 | Product used for unknown indication |
| 126530381 | 12653038 | 5 | Product used for unknown indication |
| 126530381 | 12653038 | 6 | Product used for unknown indication |
| 126530381 | 12653038 | 7 | Product used for unknown indication |
| 126530381 | 12653038 | 8 | Product used for unknown indication |
| 126530381 | 12653038 | 9 | Product used for unknown indication |
| 126530381 | 12653038 | 10 | Product used for unknown indication |
| 126530381 | 12653038 | 11 | Product used for unknown indication |
| 126530381 | 12653038 | 12 | Product used for unknown indication |
| 126530381 | 12653038 | 13 | Product used for unknown indication |
| 126530381 | 12653038 | 14 | Product used for unknown indication |
| 126530381 | 12653038 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126530381 | 12653038 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126530381 | 12653038 | Diarrhoea | |
| 126530381 | 12653038 | Hypomagnesaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |